Annual Accounts Payable
$1.52 M
-$451.00 K-22.82%
31 December 2023
Summary:
Corvus Pharmaceuticals annual accounts payable is currently $1.52 million, with the most recent change of -$451.00 thousand (-22.82%) on 31 December 2023. During the last 3 years, it has fallen by -$1.94 million (-56.01%). CRVS annual accounts payable is now -56.01% below its all-time high of $3.47 million, reached on 31 December 2020.CRVS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.87 M
+$660.00 K+54.41%
30 September 2024
Summary:
Corvus Pharmaceuticals quarterly accounts payable is currently $1.87 million, with the most recent change of +$660.00 thousand (+54.41%) on 30 September 2024. Over the past year, it has increased by +$469.00 thousand (+33.40%). CRVS quarterly accounts payable is now -61.85% below its all-time high of $4.91 million, reached on 31 March 2021.CRVS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRVS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.8% | +33.4% |
| 3 y3 years | -56.0% | -19.8% |
| 5 y5 years | -23.7% | -1.9% |
CRVS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.0% | at low | -55.7% | +54.4% |
| 5 y | 5 years | -56.0% | at low | -61.9% | +54.4% |
| alltime | all time | -56.0% | +2575.4% | -61.9% | +319.0% |
Corvus Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.87 M(+54.4%) |
| June 2024 | - | $1.21 M(-24.6%) |
| Mar 2024 | - | $1.61 M(+5.5%) |
| Dec 2023 | $1.52 M(-22.8%) | $1.52 M(+8.6%) |
| Sept 2023 | - | $1.40 M(-33.1%) |
| June 2023 | - | $2.10 M(+49.1%) |
| Mar 2023 | - | $1.41 M(-28.8%) |
| Dec 2022 | $1.98 M(+26.3%) | $1.98 M(-53.3%) |
| Sept 2022 | - | $4.23 M(+59.5%) |
| June 2022 | - | $2.65 M(+21.1%) |
| Mar 2022 | - | $2.19 M(+39.9%) |
| Dec 2021 | $1.56 M(-54.9%) | $1.56 M(-32.9%) |
| Sept 2021 | - | $2.33 M(-18.5%) |
| June 2021 | - | $2.87 M(-41.6%) |
| Mar 2021 | - | $4.91 M(+41.6%) |
| Dec 2020 | $3.47 M(+41.6%) | $3.47 M(+34.9%) |
| Sept 2020 | - | $2.57 M(-7.5%) |
| June 2020 | - | $2.78 M(-17.2%) |
| Mar 2020 | - | $3.36 M(+37.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $2.45 M(+22.5%) | $2.45 M(+28.2%) |
| Sept 2019 | - | $1.91 M(-27.6%) |
| June 2019 | - | $2.64 M(+16.5%) |
| Mar 2019 | - | $2.26 M(+13.3%) |
| Dec 2018 | $2.00 M(-42.2%) | $2.00 M(+6.0%) |
| Sept 2018 | - | $1.89 M(-16.4%) |
| June 2018 | - | $2.25 M(-35.6%) |
| Mar 2018 | - | $3.50 M(+1.3%) |
| Dec 2017 | $3.45 M(+81.8%) | $3.45 M(-3.4%) |
| Sept 2017 | - | $3.58 M(-13.6%) |
| June 2017 | - | $4.14 M(+70.9%) |
| Mar 2017 | - | $2.42 M(+27.4%) |
| Dec 2016 | $1.90 M(+20.6%) | $1.90 M(-21.4%) |
| Sept 2016 | - | $2.42 M(+83.0%) |
| June 2016 | - | $1.32 M(-16.3%) |
| Mar 2016 | - | $1.58 M(+0.1%) |
| Dec 2015 | $1.57 M(+2663.2%) | $1.57 M(+252.3%) |
| Sept 2015 | - | $447.00 K |
| Dec 2014 | $57.00 K | - |
FAQ
- What is Corvus Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual accounts payable year-on-year change?
- What is Corvus Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly accounts payable year-on-year change?
What is Corvus Pharmaceuticals annual accounts payable?
The current annual accounts payable of CRVS is $1.52 M
What is the all time high annual accounts payable for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual accounts payable is $3.47 M
What is Corvus Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CRVS annual accounts payable has changed by -$451.00 K (-22.82%)
What is Corvus Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CRVS is $1.87 M
What is the all time high quarterly accounts payable for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly accounts payable is $4.91 M
What is Corvus Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CRVS quarterly accounts payable has changed by +$469.00 K (+33.40%)